Imatinib Completed Phase 2 Trials for Health Care Evaluation / Health Care Quality Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01227356A Study Comparing Imatinib and Imatinib/Pegylated Interferon in Chronic Myeloid Leukemia